Reckitt to Buy India’s Paras Pharma for $724 Million

Reckitt Benckiser Group Plc, the maker of Lysol cleaners and Nurofen painkillers, agreed to buy India’s Paras Pharmaceuticals Ltd. for about 32.6 billion rupees ($724 million), extending its push into consumer healthcare.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.